The primary measure of ILD progression was a decline in forced vital capacity (FVC) of 5% or more between annual visits.

David Spigel, MD, medical oncologist and the chief scientific officer at Sarah Cannon Research Institute in Nashville, Tennessee, discusses the pivotal findings from the AIM-HIGH trial (NCT01817192), ...

Older patients with small cell lung cancer and significant weight loss were more likely to experience dose interruptions than ...

Australia has launched its first lung cancer screening program, which targets current and recent smokers with biennial ...

Sanofi and Regeneron, AstraZeneca, Roche’s Genentech and GSK have provided support for the Living Well with COPD educational ...

Merck & Co. Inc. is acquiring Verona Pharma PLC in a $10 billion deal that will expand the pharmaceutical giant's portfolio of chronic obstructive pulmonary disease treatments with Verona Pharma's ...

Merck said it will buy Verona Pharma for $10 billion to bolster its lung-disease business and help replace the expected loss ...

Pharmaceutical giant Merck is buying Verona Pharma, a company that concentrates its efforts on respiratory diseases, in an ...

--Merck is nearing a roughly $10 billion deal to buy lung disease-focused drugmaker Verona Pharma, the Financial Times reports, citing people familiar with the matter. --Merck would pay $107 per ...

Kasing Lung is the creative mind behind the beloved Labubu figures, blending playful storytelling and street art to capture the hearts of toy and art collectors worldwide.

A new study that found high levels of heavy metals in popular nicotine vapes adds to concerns about the products.

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and ...